NIAID Banner Logo Image

Mycobacterium Citations List: April, 2016

Literature Citations

1. Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium in Vitro. Bax, H.I., I.A. Bakker-Woudenberg, M.T. Ten Kate, A. Verbon, and J.E. de Steenwinkel. Antimicrobial Agents Chemotherapy, 2016. 60(4): p. 2577-2579. PMID[26883697]. PMCID[PMC4808172].
[PubMed]. TB_04_2016.


2. Novel Nicotine Analogues with Potential Anti-mycobacterial Activity. Gandhi, P.T., T.N. Athmaram, and G.R. Arunkumar. Bioorganic & Medicinal Chemistry, 2016. 24(8): p. 1637-1647. PMID[26951892].
[PubMed]. TB_04_2016.


3. N-Benzyl-4-((heteroaryl)methyl)benzamides: A New Class of Direct NADH-dependent 2-trans Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors with Antitubercular Activity. Guardia, A., G. Gulten, R. Fernandez, J. Gomez, F. Wang, M. Convery, D. Blanco, M. Martinez, E. Perez-Herran, M. Alonso, F. Ortega, J. Rullas, D. Calvo, L. Mata, R. Young, J.C. Sacchettini, A. Mendoza-Losana, M. Remuinan, L. Ballell Pages, and J. Castro-Pichel. ChemMedChem, 2016. 11(7): p. 687-701. PMID[26934341].
[PubMed]. TB_04_2016.


4. Synthesis, Biological Evaluation and Structure-Activity Relationship of 2-Styrylquinazolones as Anti-tubercular Agents. Jadhavar, P.S., T.M. Dhameliya, M.D. Vaja, D. Kumar, J.P. Sridevi, P. Yogeeswari, D. Sriram, and A.K. Chakraborti. Bioorganic & Medicinal Chemistry Letters, 2016. 26(11): p. 2663-2669. PMID[27095514].
[PubMed]. TB_04_2016.


5. Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. Jnawali, H.N., D. Jeon, M.C. Jeong, E. Lee, B. Jin, S. Ryoo, J. Yoo, I.D. Jung, S.J. Lee, Y.M. Park, and Y. Kim. Journal of Natural Products, 2016. 79(4): p. 961-969. PMID[26974691].
[PubMed]. TB_04_2016.


6. Antimycobacterial Activity of Methanolic Plant Extract of Artemisia capillaris Containing Ursolic acid and Hydroquinone against Mycobacterium tuberculosis. Jyoti, M.A., K.W. Nam, W.S. Jang, Y.H. Kim, S.K. Kim, B.E. Lee, and H.Y. Song. Journal of Infection and Chemotherapy, 2016. 22(4): p. 200-208. PMID[26867795].
[PubMed]. TB_04_2016.


7. Novel Morpholinoquinoline Nucleus Clubbed with Pyrazoline Scaffolds: Synthesis, Antibacterial, Antitubercular and Antimalarial Activities. Karad, S.C., V.B. Purohit, P. Thakor, V.R. Thakkar, and D.K. Raval. European Journal of Medicinal Chemistry, 2016. 112: p. 270-279. PMID[26900659].
[PubMed]. TB_04_2016.


8. Fragment-based Approaches to the Development of Mycobacterium Tuberculosis CYP121 Inhibitors. Kavanagh, M.E., A.G. Coyne, K.J. McLean, G.G. James, C.W. Levy, L.B. Marino, L.P. de Carvalho, D.S. Chan, S.A. Hudson, S. Surade, D. Leys, A.W. Munro, and C. Abell. Journal of Medicinal Chemistry, 2016. 59(7): p. 3272-3302. PMID[27002486]. PMCID[PMC4835159].
[PubMed]. TB_04_2016.


9. Combination of Anti-tuberculosis Drugs with Vitamin C or NAC against Different Staphylococcus aureus and Mycobacterium tuberculosis Strains. Khameneh, B., B.S. Fazly Bazzaz, A. Amani, J. Rostami, and N. Vahdati-Mashhadian. Microbial Pathogenesis, 2016. 93: p. 83-87. PMID[26602814].
[PubMed]. TB_04_2016.


10. Synthesis and Antimycobacterial Activity of N-(2-Aminopurin-6-yl) and N-(Purin-6-yl) Amino acids and Dipeptides. Krasnov, V.P., A.Y. Vigorov, V.V. Musiyak, I.A. Nizova, D.A. Gruzdev, T.V. Matveeva, G.L. Levit, M.A. Kravchenko, S.N. Skornyakov, O.B. Bekker, V.N. Danilenko, and V.N. Charushin. Bioorganic & Medicinal Chemistry Letters, 2016. 26(11): p. 2645-2648. PMID[27107949].
[PubMed]. TB_04_2016.


11. Design, Syntheses, and Anti-tuberculosis Activities of Conjugates of Piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-Dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-Phenylacetyl cephalosporins. Majewski, M.W., R. Tiwari, P.A. Miller, S. Cho, S.G. Franzblau, and M.J. Miller. Bioorganic & Medicinal Chemistry Letters, 2016. 26(8): p. 2068-2071. PMID[26951749]. PMCID[PMC4824297].
[PubMed]. TB_04_2016.


12. In Vitro Antimycobacterial and Cytotoxic Data on Medicinal Plants Used to Treat Tuberculosis. Nguta, J.M., R. Appiah-Opong, A.K. Nyarko, D. Yeboah-Manu, P.G. Addo, I.D. Otchere, and A. Kissi-Twum. Data in Brief, 2016. 7: p. 1124-1130. PMID[27115026]. PMCID[PMC4833128].
[PubMed]. TB_04_2016.


13. New Direct Inhibitors of InhA with Antimycobacterial Activity Based on a Tetrahydropyran Scaffold. Pajk, S., M. Zivec, R. Sink, I. Sosic, M. Neu, C.W. Chung, M. Martinez-Hoyos, E. Perez-Herran, D. Alvarez-Gomez, E. Alvarez-Ruiz, A. Mendoza-Losana, J. Castro-Pichel, D. Barros, L. Ballell-Pages, R.J. Young, M.A. Convery, L. Encinas, and S. Gobec. European Journal of Medicinal Chemistry, 2016. 112: p. 252-257. PMID[26900657].
[PubMed]. TB_04_2016.


14. Combined Bioinformatic and Rational Design Approach to Develop Antimicrobial Peptides against Mycobacterium tuberculosis. Pearson, C.S., Z. Kloos, B. Murray, E. Tabe, M. Gupta, J.H. Kwak, P. Karande, K.A. McDonough, and G. Belfort. Antimicrobial Agents and Chemotherapy, 2016. 60(5): p. 2757-2764. PMID[26902758].
[PubMed]. TB_04_2016.


15. Click-based Synthesis and Antitubercular Evaluation of Novel Dibenzo[b,d]thiophene-1,2,3-triazoles with Piperidine, Piperazine, Morpholine and Thiomorpholine Appendages. Pulipati, L., P. Yogeeswari, D. Sriram, and S. Kantevari. Bioorganic & Medicinal Chemistry Letters, 2016. 26(11): p. 2649-2654. PMID[27101894].
[PubMed]. TB_04_2016.


16. In Vitro Activity of Selected West African Medicinal Plants against Mycobacterium ulcerans Disease. Tsouh Fokou, P.V., A.A. Kissi-Twum, D. Yeboah-Manu, R. Appiah-Opong, P. Addo, L.R. Tchokouaha Yamthe, A. Ngoutane Mfopa, F. Fekam Boyom, and A.K. Nyarko. Molecules, 2016. 21(4): E445. PMID[27089314].
[PubMed]. TB_04_2016.

Patent Citations

17. Formulations Having Anti-inflammatory Activity and Antimicrobial Activity against Gram-positive Bacteria. James-Meyer, L.S. and G.C. Coles. Patent. 2016. 2015-US56111 2016061561: 43pp.

[Patent]. TB_04_2016.


18. Polymer Composed of Repeat Units Having a Biologically Active Molecule Attached Thereto via a pH-sensitive Bond. Ouberai, M.M. and M. Welland. Patent. 2016. 2015-GB53007 2016059391: 114pp.

[Patent]. TB_04_2016.


19. Substituted 1,2,3-Triazol-1-yl-methyl-2,3-dihydro-2-methyl-6-nitroimidazo[2,1-b]oxazoles as Anti-mycobacterial Agents and a Process for the Preparation Thereof. Yempalla, K.R., G. Munagala, S. Singh, S. Sharma, I.A. Khan, R.A. Vishwakarma, and P.P. Singh. Patent. 2016. 2015-IN50111 2016063298: 35pp.

[Patent]. TB_04_2016.


20. Nargenicin Compounds and Uses Thereof as Antibacterial Agents. Young, K., D.B. Olsen, S.B. Singh, J. Su, R.R. Wilkening, J.M. Apgar, D. Meng, D. Parker, M. Mandal, L. Yang, R.E. Painter, Q. Dang, and T. Suzuki. Patent. 2016. 2014-CN89204 2016061772: 167pp.

[Patent]. TB_04_2016.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2024